MammoCAT™ is based on our proprietary slot scanning technology. This produces images of significantly higher contrast and resolution (up to 25 microns) and almost eliminates scattered radiation without using a scatter removal grid. Today’s Full Field Digital Mammography (FFDM) mammography systems use grids to remove scatter and therefore require higher X-ray doses to get acceptable images. MammoCAT™ DM, our first product, will provide superior FFDM images and can be upgraded in the field to our second product, MammoCAT™ DBT, that will rival Digital Breast Tomosynthesis systems currently on the market. Our proprietary technology gives our DBT product the same advantages that it provides to MammoCAT™ DM.
The MammoCAT™ technology platform affords superior image quality, low dose and patient comfort all in one system. Cost-effectiveness is also what separates the MammoCAT™ from all current mammography systems now in clinical use.
The MammoCAT™ DM and DBT products are currently under development and are not available for sale at this time.